PLAYDASH Media
August 5, 2026
Press Release — Source: PR Newswire Asia. Content supplied by the issuing organization.
CHANGZHOU, China , Aug. 5, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, today announced its unaudited financial results for the six months ended March 31, 2026.
First Half of Fiscal Year 2026 Financial Summary
Gross profit remained relatively stable at $2.4 million for the six months ended March 31, 2026 and 2025.
Gross margin was 26.9% for the six months ended March 31, 2026, compared to 24.3% for the same period of last year.
Basic and diluted loss per share were $0.01 for the six months ended March 31, 2026 and 2025.
First Half of Fiscal Year 2026 Financial Results
Revenue
For the Six Months Ended March 31,
2026
2025
($ millions)
Cost of Revenue
Gross Margin
Wheelchair
7.1
5.2
27.3
%
7.3
5.5
23.7
Wheelchair components
1.1
0.8
28.7
1.0
24.2
Other products
0.7
0.5
19.0
1.6
1.2
27.0
Total
8.9
6.5
26.9
9.9
7.5
24.3
Cost of Revenue and Related Tax
Gross Profit and Gross Margin
Gross profit remained relatively stable at $2.4 million for the six months ended March 31, 2026 and 2025.
Gross margin increased to 26.9% for the six months ended March 31, 2026, from 24.3% for the same period of last year. The increase was primarily attributable to higher variable costs for our standard and economy wheelchair products in the prior-year comparable period, when the Company utilized certain high-unit-price components without corresponding selling price increases to improve inventory turnover efficiency .
Operating Expenses
Our general and administrative expenses remained relatively stable at $1.4 million for the six months ended March 31, 2026 and 2025.
Other Income, Net
Net Income (Loss)
Basic and Diluted Loss per Share
Basic and diluted loss per share were $0.01 for the six months ended March 31, 2026 and 2025.
Financial Condition
About JIN MEDICAL INTERNATIONAL LTD.
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may", "will", "should", "intend", "plan", "strive", "believe", "expect", "anticipate", "project", "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission ("SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
ir@jinmed.com
